multipl
sclerosi
ms
progress
inflammatori
andor
demyelin
diseas
human
central
nervou
system
cn
knowledg
pathogenesi
ms
deriv
murin
model
experiment
autoimmun
encephalomyel
viral
encephalomyel
infect
femal
mice
neurotrop
strain
mous
hepat
viru
evalu
whether
treatment
multifunct
antioxid
tempol
affect
ensu
encephalomyel
untreat
anim
neurolog
symptom
develop
quickli
infect
mice
die
day
viru
inocul
survivor
present
neurolog
deficit
treatment
tempol
mgkg
ip
two
dose
first
day
daili
dose
day
plu
mm
tempol
drink
water
ad
libitum
profoundli
alter
diseas
outcom
neurolog
symptom
attenu
mous
surviv
increas
half
survivor
behav
normal
mice
surprisingli
tempol
substanti
preserv
integr
cn
includ
bloodbrain
barrier
furthermor
treatment
tempol
decreas
cn
viral
titer
macrophag
lymphocyt
infiltr
level
marker
inflamm
express
induc
nitric
oxid
synthas
transcript
tumor
necrosi
protein
nitrat
result
indic
tempol
amelior
murin
viral
encephalomyel
alter
redox
statu
infecti
environ
contribut
attenu
cn
inflammatori
respons
overal
studi
support
develop
therapeut
strategi
base
nitroxid
manag
neuroinflammatori
diseas
includ
ms
multipl
sclerosi
ms
progress
inflammatori
andor
demyelin
diseas
human
central
nervou
system
incid
per
individu
ms
promin
chronic
neurolog
diseas
young
adult
moder
climat
area
northern
southern
hemispher
clear
genet
influenc
complex
diseas
ms
like
involv
inherit
array
genet
polymorph
exert
slight
effect
diseas
establish
progress
environment
factor
also
recogn
contributor
ms
although
view
infecti
agent
encount
earli
life
may
prime
trigger
diseas
process
manifest
later
life
wide
support
incontrovert
evid
direct
viral
bacteri
trigger
ms
yet
provid
rel
inaccess
sensit
human
central
nervou
system
cn
knowledg
pathogenesi
ms
deriv
experiment
anim
model
murin
experiment
autoimmun
encephalomyel
eae
murin
viral
encephalomyel
although
trigger
ms
remain
scrutini
wide
accept
immunemedi
inflammatori
respons
induc
lymphocyt
macrophag
microglia
cn
particip
pathogenesi
diseas
result
inflammatori
environ
favor
high
rate
superoxid
anion
nitric
oxid
format
nadph
oxidas
induc
nitric
oxid
synthas
ino
respect
primari
radic
lead
speci
reactiv
toward
biomolecul
peroxynitrit
nitrogen
dioxid
carbon
radic
myeloperoxidas
compound
turn
may
propag
inflammatori
cascad
andor
trigger
degen
cascad
lead
nitrooxid
damag
neural
tissu
accordingli
presenc
residu
protein
marker
nitrooxid
damag
consist
demonstr
acut
chronic
activ
ms
lesion
anim
model
human
patient
see
instanc
particularli
effect
compound
deactiv
nitrogen
dioxid
carbon
radic
enzym
myeloperoxidas
cyclic
nitroxid
radic
tempol
physiolog
condit
nitroxid
tempol
tpno
act
multifunct
antioxid
react
divers
biolog
oxid
reduct
recycl
oxammonium
cation
tpno
hydroxylamin
deriv
tpnoh
respect
sever
catalyt
cycl
tempol
eventu
consum
recombin
reaction
specif
radic
tyrosyl
thiyl
radic
andor
metabol
nearli
catalyt
antioxid
properti
like
contribut
effici
tempol
reduc
tissu
injuri
anim
model
inflamm
review
ref
best
knowledg
peerreview
studi
report
effect
tempol
anim
model
ms
although
patent
recent
publish
wo
case
describ
exampl
obtain
murin
eae
model
show
strike
effect
tempol
amelior
murin
viral
encephalomyel
induc
neurotrop
strain
mous
hepat
viru
monitor
diseas
score
mous
surviv
cn
integr
viral
load
marker
inflamm
also
provid
mechanist
clue
amelior
action
tempol
reagent
purchas
sigma
merck
fisher
analyt
grade
better
solut
prepar
distil
water
purifi
barnstead
milliq
system
strain
coronaviru
mhv
obtain
laboratoir
de
virologi
strasburg
franc
viru
propag
plaqu
assay
cell
cultur
modifi
eagl
medium
contain
fetal
bovin
serum
previous
describ
infect
mice
tempol
treatment
spf
femal
mice
week
age
obtain
anim
facil
experi
perform
follow
approv
anim
guidelin
committe
anim
ethic
instituto
de
universidad
de
paulo
anim
intracrani
inocul
ic
left
cerebr
hemispher
solut
contain
viru
pfu
dilut
phosphatebuff
salin
pb
contain
bovin
serum
albumin
bsa
pb
plu
bsa
control
anim
inject
locat
deep
cortic
layer
pariet
cortex
close
corpu
callosum
verifi
pilot
experi
thawmount
brain
section
anim
inject
evan
blue
tempol
mgkg
administ
intraperiton
ip
two
dose
first
day
min
h
inocul
daili
dose
day
anim
also
receiv
tempol
mm
drink
water
ad
libitum
untreat
anim
inocul
viru
receiv
pb
ip
instead
tempol
sham
anim
receiv
pb
plu
bsa
intracrani
instead
viru
treat
tempol
mice
examin
clinic
symptom
score
previous
describ
summari
normal
mice
score
mildli
sick
anim
show
piloerect
hunch
postur
lethargi
score
moder
sick
mice
show
hindor
forelimb
weaknessparesi
lethargi
score
sever
sick
anim
hindor
forelimb
paralysi
lethargi
deplet
atax
gait
score
moribund
mice
score
dead
anim
score
mice
euthan
lethal
dose
thiopent
ip
collect
tissu
sampl
interrupt
experi
day
infect
mice
euthan
lethal
dose
thiopent
ip
perfus
intracardi
ml
buffer
formalin
brain
remov
formalinfix
paraffinembed
stain
hematoxylin
eosin
evalu
infiltr
use
weil
demyelin
assess
mous
brain
spinal
cord
tissu
collect
weigh
homogen
dmem
supplement
fetal
bovin
serum
gentamycin
homogen
mgml
serial
dilut
plaqu
assay
cell
analysi
tempol
hydroxylamin
deriv
electron
paramagnet
reson
epr
epr
spectra
record
room
temperatur
bruker
er
dsrc
upgrad
emx
instrument
mice
sacrif
min
tempol
administr
mgkg
ip
brain
tissu
collect
homogen
pb
mlg
tissu
subject
epr
analysi
determin
tempol
level
addit
mm
ferricyanid
determin
tempol
plu
hydroxylamin
level
tempol
concentr
brain
estim
doubl
integr
epr
spectrum
comparison
standard
tempol
solut
scan
condit
determin
level
tempol
brain
anim
receiv
mm
tempol
drink
water
anim
sacrif
brain
tissu
collect
homogen
analyz
epr
describ
sodium
fluorescein
use
tracer
previous
describ
modif
briefli
mice
receiv
sodium
fluorescein
pb
ip
min
later
anesthet
bled
transcardi
perfus
minimum
ml
pb
heparin
unitsl
pb
blood
brain
spinal
cord
collect
analysi
brain
wash
pb
photograph
spinal
cord
weigh
homogen
pb
mlspinal
cord
centrifug
g
min
sampl
clarifi
supernat
use
determin
total
protein
concentr
biorad
kit
parallel
ml
clarifi
supernat
mix
ml
trichloroacet
acid
centrifug
g
min
addit
ml
naoh
ml
supernat
fluoresc
determin
use
fluorolog
fluorimet
spex
nm
excit
nm
emiss
sodium
fluorescein
standard
ngml
use
determin
fluorescein
content
sampl
blood
centrifug
level
fluorescein
sera
determin
fluorescein
uptak
circul
spinal
cord
tissu
express
fluoresc
spinal
cord
tissu
mg
protein
fluoresc
blood
normal
valu
blood
level
marker
day
infect
mice
euthan
lethal
dose
thiopent
ip
perfus
intracardi
via
left
ventricl
ml
pb
follow
ml
buffer
formalin
brain
spinal
cord
remov
kept
buffer
formalin
h
tissu
section
paraffinembed
coron
section
obtain
affix
onto
slide
slide
sequenti
deparaffin
rehydr
treat
hydrogen
peroxid
min
block
endogen
peroxidas
activ
antigen
retriev
incub
slide
citrat
buffer
ph
min
pressur
cooker
case
antinitrotyrosin
trisedta
buffer
ph
min
veget
steamer
antiino
final
slide
incub
overnight
primari
antibodi
dilut
bsa
employ
antibodi
dilut
mous
monoclon
nitrotyrosin
abcam
uk
rabbit
polyclon
ino
abcam
monoclon
antimous
cedarlan
canada
extens
wash
tbstween
section
incub
humidifi
chamber
novolink
max
polym
novocastra
uk
accord
instruct
manufactur
antinitrotyrosin
antiino
antibodi
case
antibodi
section
incub
avidin
biotinyl
peroxidas
complex
abc
use
abc
vectastain
elit
kit
vector
laboratori
burlingam
ca
usa
accord
instruct
manufactur
avidinbiotin
complex
visual
sigma
st
loui
mo
usa
hydrogen
peroxid
counterstain
perform
harri
hematoxylin
merck
darmstadt
germani
assess
nonspecif
stain
sampl
similarli
treat
absenc
primari
antibodi
marker
macrophag
cell
ino
immunoreact
measur
region
forebrain
semiquantit
bilater
imag
analysi
two
sectionsmous
three
anim
implement
kontronzeiss
imag
analyz
germani
previous
describ
briefli
televis
camera
microscop
acquir
imag
field
select
within
brain
region
cortic
area
amygdaloid
nuclei
hippocampu
corpu
callosum
bilater
size
sampl
field
cortic
area
amygdaloid
nuclei
hippocampu
corpu
callosum
shade
correct
follow
discrimin
procedur
perform
mean
valu
gray
matter
mgv
standard
error
area
brain
devoid
specif
label
taken
background
gray
valu
darker
background
consid
correspond
specif
label
discrimin
specif
mgv
taken
differ
specif
background
valu
glass
valu
left
constant
mgv
morphometr
area
microdensitometr
measur
specif
mgv
indic
amount
immunoposit
profil
sampl
field
area
immunolabel
present
day
infect
mice
euthan
lethal
dose
thiopent
ip
spinal
cord
tissu
collect
immedi
frozen
liquid
nitrogen
frozen
tissu
pulver
pestl
mortar
contain
liquid
nitrogen
homogen
lysi
buffer
mlspinal
cord
contain
mm
tri
ph
triton
mm
edta
proteas
inhibitor
trypsin
inhibitor
mm
sodium
orthovanad
benzamidin
antipain
hydrochlorid
proteas
inhibit
cocktail
tissu
vv
sigma
homogen
centrifug
g
min
supernat
store
analysi
total
protein
nitrat
protein
protein
total
protein
sampl
determin
bradford
method
biorad
kit
sampl
spinal
cord
homogen
transfer
onto
nitrocellulos
membran
vacuum
slot
blot
assess
blot
protein
perform
ponceau
stain
previous
describ
destain
done
distil
water
membran
block
nonfat
dri
milk
h
exposur
primari
antibodi
solut
h
mous
monoclon
antinitrotyrosin
abcam
primari
antibodi
detect
h
incub
secondari
antibodi
peroxidaseconjug
rabbit
polyclon
mous
igg
abcam
slot
blot
reveal
chemiluminesc
reagent
amersham
rel
quantif
perform
densitometri
imagequ
version
molecular
dynam
mice
euthan
day
infect
analysi
day
infect
analysi
lethal
dose
thiopent
ip
spleen
andor
spinal
cord
immedi
remov
total
rna
extract
use
trizol
reagent
invitrogen
follow
instruct
manufactur
rna
concentr
determin
uv
spectroscopi
nm
total
rna
revers
transcrib
cdna
super
script
firststrand
synthesi
system
rtpcr
invitrogen
follow
instruct
manufactur
amplif
cdna
perform
accord
instruct
manufactur
pcr
master
mix
promega
thermal
cycler
mj
research
ptc
protocol
transcript
detect
follow
case
predenatur
min
cycl
denatur
anneal
extens
repeat
cycl
final
end
extens
min
predenatur
min
cycl
denatur
anneal
extens
repeat
cycl
final
end
extens
min
predenatur
min
cycl
denatur
anneal
extens
repeat
cycl
predenatur
min
cycl
denatur
anneal
extens
repeat
cycl
final
end
extens
min
follow
primer
use
pcr
amplif
primer
bp
primer
bp
primer
bp
primer
bp
primer
bp
pcr
product
analyz
agaros
gel
stain
ethidium
bromid
rel
quantif
transcript
perform
densitometri
imagequ
version
molecular
dynam
data
express
mean
standard
error
differ
experiment
group
examin
use
unpair
test
outcom
viral
infect
depend
varieti
factor
host
age
sex
genet
viru
strain
mutabl
dose
rout
administr
thu
start
examin
characterist
infect
experiment
set
spf
femal
mice
n
receiv
pb
ip
surrog
ulterior
tempol
treatment
intracrani
inocul
pfu
maintain
observ
one
day
infect
anim
show
mild
neurolog
symptom
piloerect
hunch
postur
lethargi
score
fig
day
inocul
mice
improv
least
show
moder
sever
neurolog
symptom
hindor
forelimb
weaknessparesi
score
hindor
forelimb
paralysi
atax
gait
score
day
infect
mice
die
ten
day
inocul
mice
die
survivor
still
present
neurolog
symptom
persist
day
fig
histopatholog
analysi
brain
tissu
collect
day
inocul
show
massiv
inflammatori
cellular
infiltr
throughout
forebrain
gray
white
matter
region
fig
inflammatori
foci
accumul
increas
amount
infiltr
cell
evid
gray
matter
region
neocortex
hippocampu
amygdala
diencephalon
also
white
matter
structur
later
region
corpu
callosum
intern
capsul
anterior
commissur
fornix
moreov
periven
cuf
particularli
seen
white
matter
cluster
mainli
associ
perivenular
disrupt
myelin
stain
weil
fig
thu
confirm
infect
spf
femal
mice
model
certain
aspect
cn
inflamm
associ
ms
use
test
effect
tempol
treatment
function
analyt
studi
demonstr
tempol
penetr
bloodbrain
barrier
review
confirm
epr
analysi
brain
homogen
sham
mice
sacrif
min
tempol
administr
mgkg
ip
fig
usual
biolog
fluid
tissu
tempol
present
reduc
form
correspond
hydroxylamin
inde
characterist
epr
signal
tempol
becam
notic
upon
addit
ferricyanid
homogen
total
tempol
nitroxid
plu
hydroxylamin
level
decay
quickli
vivo
attain
brain
min
administr
maximum
level
measur
min
administr
sham
mice
lower
level
total
tempol
detect
infect
mice
min
consist
cours
infect
produc
radic
abl
react
tempol
gener
redox
inact
product
despit
fast
metabol
tempol
mice
fig
treatment
mice
compound
profoundli
alter
outcom
diseas
exampl
neurolog
symptom
cn
infiltr
demyelin
greatli
reduc
fig
mous
surviv
significantli
increas
fig
inde
histopatholog
analysi
forebrain
region
tempoltr
mice
reveal
dramat
reduct
inflammatori
cell
infiltr
throughout
forebrain
gray
white
matter
region
addit
periven
accumul
inflammatori
cell
disrupt
weil
myelin
stain
substanti
reduc
compar
fig
wherea
untreat
mice
die
day
infect
mice
treat
tempol
surviv
fig
half
display
behavior
normal
mice
fig
strike
effect
obtain
tempol
administr
mgkg
ip
two
dose
first
day
min
h
inocul
daili
dose
day
anim
also
receiv
tempol
mm
drink
water
ad
libitum
advers
effect
treatment
observ
uninfect
mice
fig
previous
shown
tempol
administ
drink
water
distribut
tissu
examin
cn
tissu
determin
level
total
tempol
tempol
plu
hydroxylamin
brain
spinal
cord
plasma
mice
receiv
mm
tempol
drink
water
level
similar
around
data
shown
gain
insight
mechan
tempol
amelior
viral
encephalomyel
first
examin
whether
nitroxid
fig
b
repres
hematoxylineosinand
weilstain
bottom
right
section
brain
mice
treat
tempol
day
postinfect
region
label
co
cortic
area
amyg
amygdaloid
nucleu
hip
hippocampu
cc
corpu
callosum
contrast
brain
untreat
mice
fig
massiv
inflammatori
cellular
infiltr
loci
myelin
disrupt
larg
absent
affect
viral
load
cn
tabl
one
day
inocul
viru
titer
undetect
plaqu
assay
cn
untreat
tempoltr
mice
time
first
anim
die
day
inocul
viru
titer
high
brain
spinal
cord
untreat
mice
significantli
reduc
mice
treat
tempol
tabl
next
examin
bloodbrain
barrier
bbb
integr
loss
associ
sever
neurolog
diseas
includ
ms
end
uptak
fluidphas
marker
sodium
fluorescein
assess
quantit
qualit
spinal
cord
brain
mice
respect
result
show
day
inocul
mark
increas
permeabl
bbb
untreat
mice
fig
contrast
tempoltr
anim
present
remark
preserv
bbb
addit
loss
bloodbrain
barrier
integr
cn
inflamm
crucial
event
pathogenesi
ms
thu
complement
histopatholog
analysi
cn
tissu
mice
fig
immunohistochem
rtpcr
analysi
marker
inflamm
immunohistochem
analysi
brain
fig
spinal
cord
data
shown
tissu
show
viral
infect
result
macrophag
infiltr
ino
express
protein
nitrat
greatli
attenu
tempol
treatment
brain
section
infect
mice
activ
glial
cell
strongli
stain
nitrat
protein
notic
fig
bottom
left
semiquantit
imag
analysi
immunostain
brain
tissu
reveal
treatment
tempol
reduc
macrophag
infiltr
ino
express
level
untreat
mice
respect
fig
quantif
level
spinal
cord
anim
immun
slot
blot
confirm
tempol
inhibit
level
untreat
mice
fig
treatment
tempol
also
greatli
reduc
level
mrna
spinal
cord
anim
assess
rtpcr
fig
cytokin
produc
cell
involv
immun
inflammatori
respons
viral
encephalomyel
review
thu
also
quantifi
level
mrna
spinal
cord
spleen
anim
treatment
tempol
decreas
infiltr
lymphocyt
spinal
cord
although
differ
mrna
level
statist
signific
fig
tempol
alter
level
transcript
spleen
fig
indic
preserv
immun
statu
treat
anim
naiv
mice
present
lower
level
transcript
fig
infect
anim
fig
infer
rel
intens
correspond
band
result
demonstr
tempol
strongli
inhibit
cn
inflamm
mice
without
compromis
immun
system
fig
result
report
show
treatment
tempol
quit
effect
amelior
virusinduc
murin
encephalomyel
experiment
set
neurolog
symptom
cn
alter
develop
quickli
mice
die
day
viru
inocul
fig
treatment
tempol
attenu
neurolog
symptom
increas
surviv
fig
notabl
half
survivor
behav
normal
mice
least
kept
low
dose
tempol
drink
water
mm
surprisingli
treatment
tempol
substanti
preserv
integr
cn
compar
fig
includ
bbb
fig
effect
tempol
preserv
neurolog
behavior
cn
integr
infect
mice
accompani
pronounc
reduct
infiltr
macrophag
tabl
viru
titer
cn
femal
mice
treat
tempol
day
postinfect
dpi
viru
titer
log
pfumg
tissu
lymphocyt
cn
fig
system
cell
decreas
exclud
major
immunosuppress
effect
tempol
fig
treatment
tempol
also
reduc
tissu
level
marker
inflamm
express
ino
transcript
protein
nitrat
fig
anim
inhibit
protein
nitrat
higher
ino
express
fig
b
indic
tempol
act
antioxid
regul
ino
express
antioxid
action
tempol
virusinduc
encephalomyel
also
reveal
faster
decay
rate
tempol
plu
hydroxylamin
brain
infect
mice
compar
sham
mice
fig
indic
infecti
process
gener
consider
amount
radic
abl
react
tempol
produc
redoxinact
product
consequ
tempol
alter
redox
statu
infecti
environ
fig
hand
increasingli
recogn
redox
statu
extraand
intracellular
microenviron
influenc
outcom
infectiousinflammatori
process
thu
like
tempol
attenu
cn
inflammatori
respons
amelior
viral
encephalomyel
fig
alter
redox
statu
infecti
environ
fig
regard
studi
support
argument
antioxid
antiinflammatori
action
tempol
like
interrel
effect
tempol
redox
signal
cascad
involv
inflammatori
process
howev
remain
poorli
investig
molecular
level
phenomenolog
level
tempol
previous
shown
display
antiinflammatori
properti
mous
model
infectiousinflammatori
diseas
instanc
tempol
administr
decreas
level
mrna
inhibit
activ
mice
subject
carrageenaninduc
pleuriti
inhibit
ino
express
murin
leishmaniasi
case
mice
treatment
tempol
reduc
level
ino
protein
fig
viral
load
cn
tabl
reduct
viral
load
contrast
previou
observ
reduc
ino
express
protein
nitrat
murin
leishmaniasi
tempol
increas
parasit
load
cutan
lesion
opposit
effect
nitric
oxidederiv
oxid
differ
infecti
diseas
like
result
divers
mode
microbi
replic
invas
host
tissu
contrast
bacteria
parasit
viru
confin
limit
area
nonspecif
host
defens
mediat
phagocyt
mediat
consequ
nitric
oxidederiv
oxid
like
caus
nonspecif
nitrooxid
damag
virusinfect
tissu
elimin
viru
accordingli
report
infect
ino
knockout
ino
mice
mhv
result
similar
kinet
viru
clearanc
reduc
neuron
apoptosi
mortal
follow
kinet
viru
clearanc
experiment
set
show
day
infect
tempol
reduc
viral
load
ino
express
cn
damag
thu
feasibl
decreas
nitrooxid
stress
tempol
attenu
mutat
rate
viru
preclud
evolut
mutant
abl
escap
antivir
immun
respons
host
addit
tempol
taken
togeth
result
indic
tempol
amelior
murin
viral
encephalomyel
alter
redox
statu
infecti
environ
contribut
attenu
cn
inflammatori
respons
fig
thu
studi
argu
interrelated
antioxid
antiinflammatori
action
tempol
cross
talk
howev
remain
examin
molecular
level
regard
therapeut
implic
import
note
natur
antioxid
uric
acid
shown
quit
effect
amelior
eae
inhibit
cn
inflamm
bbb
dysfunct
tissu
damag
discoveri
motiv
initi
clinic
trial
inosin
metabol
precursor
uric
acid
oral
administr
inosin
increas
uric
acid
level
serum
cerebrospin
fluid
wherea
oral
dose
uric
acid
mostli
degrad
uricas
gastrointestin
tract
amelior
effect
uric
acid
eae
attribut
abil
scaveng
nitric
oxidederiv
oxid
comparison
tempol
effect
uric
acid
scaveng
nitric
oxidederiv
oxid
display
low
toxic
anim
model
permeat
bloodbrain
barrier
fig
inhibit
enzym
myeloperoxidas
see
augusto
et
al
recent
associ
ms
context
report
amelior
effect
tempol
viral
murin
encephalomyel
provid
support
develop
therapeut
strategi
base
nitroxid
manag
neuroinflammatori
diseas
includ
ms
